Prologis, Inc. (PLD) Stock Forecast
Data as of Aug 1, 2026Real Estate · Current price $145.31 (-0.66%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 17, 2026 | Steve Sakwa | Evercore ISI | $135.00 | -7.1% |
| Feb 2, 2026 | Michael Carroll | RBC Capital | $135.00 | -7.1% |
| Jan 26, 2026 | Michael Lewis | Truist Financial | $139.00 | -4.3% |
| Jan 22, 2026 | Marie Ferguson | Argus Research | $135.00 | -7.1% |
| Jan 16, 2026 | Ronald Kamdem | Morgan Stanley | $135.00 | -7.1% |
| Jan 14, 2026 | Nicholas Yulico | UBS | $146.00 | +0.5% |
| Jan 8, 2026 | Nicholas Thillman | Robert W. Baird | $130.00 | -10.5% |
| Oct 21, 2025 | Michael Goldsmith | UBS | $137.00 | -5.7% |
| Oct 20, 2025 | Ki Bin Kim | Truist Financial | $131.00 | -9.8% |
| Oct 20, 2025 | John Kim | BMO Capital | $119.00 | -18.1% |
| Aug 27, 2025 | Nicholas Yulico | Scotiabank | $114.00 | -21.5% |
| Aug 19, 2025 | Vikram Malhotra | Mizuho Securities | $118.00 | -18.8% |
| Jul 13, 2025 | Blaine Heck | Wells Fargo | $137.00 | -5.7% |
| May 2, 2025 | Ki Bin Kim | Truist Financial | $120.00 | -17.4% |
| Jan 8, 2025 | Vikram Malhotra | Mizuho Securities | $117.00 | -19.5% |
| Oct 21, 2024 | Caitlin Burrows | Goldman Sachs | $132.00 | -9.2% |
| Oct 16, 2024 | Caitlin Burrows | Goldman Sachs | $142.00 | -2.3% |
| Oct 16, 2024 | John Kim | BMO Capital | $122.00 | -16.0% |
| Sep 16, 2024 | Steve Sakwa | Evercore ISI | $128.00 | -11.9% |
| Aug 20, 2024 | Steve Sakwa | Evercore ISI | $122.00 | -16.0% |
Top Analysts Covering PLD
PLD vs Sector & Market
| Metric | PLD | Real Estate Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.28 | 2.60 | 2.42 |
| Analyst Count | 18 | 9 | 19 |
| Target Upside | +5.5% | +45.5% | +17.1% |
| P/E Ratio | 36.69 | 27.76 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $8.64B | $8.67B | $8.70B | 6 |
| 2027-12-31 | $8.94B | $9.20B | $9.44B | 6 |
| 2028-12-31 | $9.36B | $9.56B | $9.76B | 4 |
| 2029-03-31 | $2.33B | $2.34B | $2.36B | 3 |
| 2029-06-30 | $2.35B | $2.37B | $2.38B | 2 |
| 2029-09-30 | $2.37B | $2.39B | $2.41B | 2 |
| 2029-12-31 | $2.39B | $2.41B | $2.43B | 3 |
| 2030-03-31 | $2.41B | $2.42B | $2.44B | 3 |
| 2030-06-30 | $2.43B | $2.45B | $2.47B | 2 |
| 2030-09-30 | $2.46B | $2.47B | $2.49B | 2 |
| 2030-12-31 | $2.48B | $2.49B | $2.51B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.40 | $3.42 | $3.44 | 5 |
| 2027-12-31 | $3.69 | $3.73 | $3.77 | 6 |
| 2028-12-31 | $3.20 | $4.00 | $4.86 | 4 |
| 2029-03-31 | $0.00 | $0.00 | $0.00 | 2 |
| 2029-06-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2029-09-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2029-12-31 | $0.00 | $0.00 | $0.00 | 2 |
| 2030-03-31 | $0.00 | $0.00 | $0.00 | 2 |
| 2030-06-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2030-09-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2030-12-31 | $0.00 | $0.00 | $0.00 | 2 |
Frequently Asked Questions
What is the analyst consensus for PLD?
The consensus among 18 analysts covering Prologis, Inc. (PLD) is Buy with an average price target of $145.57.
What is the highest price target for PLD?
The highest price target for PLD is $187.00, set by Chandni Luthra at Goldman Sachs on 2022-12-14.
What is the lowest price target for PLD?
The lowest price target for PLD is $114.00, set by Nicholas Yulico at Scotiabank on 2025-08-27.
How many analysts cover PLD?
18 analysts have issued ratings for Prologis, Inc. in the past 12 months.
Is PLD a buy or sell right now?
Based on 18 analyst ratings, PLD has a consensus rating of Buy (2.28/5) with a +5.5% upside to the consensus target of $145.57.
What are the earnings estimates for PLD?
Analysts estimate PLD will report EPS of $3.42 for the period ending 2026-12-31, with revenue estimated at $8.67B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.